Mesenchymal stem cell-derived exosomes carry MicroRNA-125a to protect against diabetic nephropathy by targeting histone deacetylase 1 and downregulating …
Y Hao, J Miao, W Liu, K Cai, X Huang… - … Syndrome and Obesity, 2021 - Taylor & Francis
Background Mesenchymal stem cell (MSC)-derived exosomes have seen great advances in
human disease control in a minimally invasive manner. This research aimed to explore the …
human disease control in a minimally invasive manner. This research aimed to explore the …
Mesenchymal Stem Cell-Derived Exosomes Carry MicroRNA-125a to Protect Against Diabetic Nephropathy by Targeting Histone Deacetylase 1 and Downregulating …
Y Hao, J Miao, W Liu, K Cai, X Huang… - … Syndrome and Obesity …, 2021 - europepmc.org
Background Mesenchymal stem cell (MSC)-derived exosomes have seen great advances in
human disease control in a minimally invasive manner. This research aimed to explore the …
human disease control in a minimally invasive manner. This research aimed to explore the …
Mesenchymal Stem Cell-Derived Exosomes Carry MicroRNA-125a to Protect Against Diabetic Nephropathy by Targeting Histone Deacetylase 1 and Downregulating …
Y Hao, J Miao, W Liu, K Cai… - … and obesity: targets …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Mesenchymal stem cell (MSC)-derived exosomes have seen great advances in
human disease control in a minimally invasive manner. This research aimed to explore the …
human disease control in a minimally invasive manner. This research aimed to explore the …
Mesenchymal Stem Cell-Derived Exosomes Carry MicroRNA-l25a to Protect Against Diabetic Nephropathy by Targeting Histone Deacetylase 1 and Downregulating …
Y Hao, J Miao, W Liu, K Cai, X Huang… - … , Metabolic Syndrome and …, 2021 - go.gale.com
Background: Mesenchymal stem cell (MSC)-derived exosomes have seen great advances
in human disease control in a minimally invasive manner. This research aimed to explore …
in human disease control in a minimally invasive manner. This research aimed to explore …
[HTML][HTML] Mesenchymal Stem Cell-Derived Exosomes Carry MicroRNA-125a to Protect Against Diabetic Nephropathy by Targeting Histone Deacetylase 1 and …
Y Hao, J Miao, W Liu, K Cai, X Huang… - … Syndrome and Obesity …, 2021 - ncbi.nlm.nih.gov
Background Mesenchymal stem cell (MSC)-derived exosomes have seen great advances in
human disease control in a minimally invasive manner. This research aimed to explore the …
human disease control in a minimally invasive manner. This research aimed to explore the …
Mesenchymal Stem Cell-Derived Exosomes Carry MicroRNA-125a to Protect Against Diabetic Nephropathy by Targeting Histone Deacetylase 1 and Downregulating …
H Yan, J Miao, W Liu, K Cai… - … Syndrome and Obesity, 2021 - search.proquest.com
Background: Mesenchymal stem cell (MSC)-derived exosomes have seen great advances
in human disease control in a minimally invasive manner. This research aimed to explore …
in human disease control in a minimally invasive manner. This research aimed to explore …
Mesenchymal Stem Cell-Derived Exosomes Carry MicroRNA-125a to Protect Against Diabetic Nephropathy by Targeting Histone Deacetylase 1 and Downregulating …
Y Hao, J Miao, W Liu, K Cai, X Huang… - … Syndrome and Obesity, 2021 - dovepress.com
Background: Mesenchymal stem cell (MSC)-derived exosomes have seen great advances
in human disease control in a minimally invasive manner. This research aimed to explore …
in human disease control in a minimally invasive manner. This research aimed to explore …